Fanos Tsingis obtained his Bachelor’s degree in Chemistry from the University of Leicester in 2020. He then pursued a Master’s degree in Medicinal Chemistry at the University of Glasgow, where he graduated in 2021. His thesis, conducted in the Köhnke group, involved in-silico methodologies to identify potential anti-tubercular agents by targeting the MmpL10 and AbieEi_1 proteins unique to M. tuberculosis. Following his studies, Fanos joined the pharmaceutical sector as an R&D Associate at Medochemie, where he focused on developing analytical methods and in vitro dissolution testing of generic drug products.